IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q4 2019 Holdings

Filed 2020-02-11 | 4 holdings | $163.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Synthorx IncCOM87167A103$70.3K1,005,18443.1%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$64.4K2,067,86139.5%
Merus N VCOMN5749R100$22.5K1,600,00013.8%
Obseva SACOMH5861P103$6.0K1,570,0003.7%